Carlo Antozzi

11PUBLICATIONS
41CO-AUTHORS
Panel data analysisGene and molecular therapyNeurology and neuromuscular diseasesAllergyMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 20, 2026
Disease changes and cost analysis of myasthenia gravis: a 10 years retrospective study from a reference center in Italy.

|May 20, 2026
Evaluation of Sustained Disease Control With Nipocalimab Versus Placebo in the Phase 3 Vivacity-MG3 Study.

|Jan 06, 2026
Does myasthenia gravis impact cognitive functioning? A systematic review and meta-analysis.

Alessia Marcassoli, Giulia Trucco, Angelica Mazzilli

|Sep 29, 2025
An evaluation of nipocalimab for the treatment of generalized myasthenia gravis.

Carlo Antozzi, Marie Fitzgibbon

|Aug 04, 2025
Improvement in Patient-Reported Symptoms of Generalised Myasthenia Gravis With Rozanolixizumab in the Randomised Phase 3 MycarinG Study Using the MG Symptoms PRO.

Henry J Kaminski, Carlo Antozzi, Ali A Habib

|Jul 31, 2025
Unknown Immunoregulatory Effects of FcRn Inhibition by Efgartigimod in Myasthenia Gravis: A New Mechanism of Action Beyond IgG Reduction.

Maria Cristina Tarasco, Elena Rinaldi, Rita Frangiamore

Pageof 2

Frequent Collaborators

7 joint publications

Renato Mantegazza

5 joint publications

Lorenzo Maggi

4 joint publications

Rita Frangiamore

3 joint publications

Elena Rinaldi